Sumitomo Chemical Establishes R&D Base in Brazil

Japan’s Sumitomo Chemical has chosen Brazil as the location for its first R&D center in Latin America. The Latin America Research Center will be set up during 2016 and be operated by wholly-owned subsidiary Sumitomo Chemical Brazil. It will conduct efficacy trials, R&D, and analyses of crop protection and other related products.

The facility will be located on a site of approximately 48 hectares, comprising a research building and an experimental field. Investment costs were not disclosed.

Sumitomo said the center is expected to accelerate product development as it will be able to carry out detailed, highly reliable field trials and research, geared specifically to the climactic conditions of the Latin American market, a strategically important region for the company’s crop protection products business.

Latin America’s crop protection market has been growing rapidly in recent years and currently accounts for around 25% of the global market. Sumitomo said the region is likely to see greater growth in agricultural production in the years ahead, hence higher demand for crop protection products.

Going forward, Sumitomo said it will “vigorously work to fortify and expand the business in Latin America.”

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences

The Start-up Platform for Chemistry & Life Sciences

The tasks range from employee protection, site security and crisis management to IT, OT and production security.

Artificial Intelligence

Pierre Racz: "Real Artificial Intelligence Does Not Exist"
part one of a three-part interview series

Pierre Racz: "Real Artificial Intelligence Does Not Exist"

In part one Pierre Racz, President of Genetec, is addressing why IP network video systems were the game changer in the industry and why he does not like the term AI.

most read

Photo
24.01.2025 • News

CEFIC Publishes 2024 Facts and Figures Report

CEFIC , the European Chemical Industry Council, has published its 2024 Facts & Figures report, which reinforces the need to take bold and urgent action to secure Europe’s industrial future, not only to implement the Green Deal but also to prevent further de-industrialization in Europe.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.